These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22223379)

  • 21. Haemoglobinuria caused by propylene glycol in sheep.
    POTTER BJ
    Br J Pharmacol Chemother; 1958 Dec; 13(4):385-9. PubMed ID: 13618540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicochemical characterization and an injection formulation study of water insoluble ZCVI₄-2, a novel NO-donor anticancer compound.
    Gao Y; Li L; Zhang J; Su F; Gong Z; Lai Y; Zhang Y
    Arch Pharm Res; 2012 Jul; 35(7):1177-86. PubMed ID: 22864740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of hydrotropy to transdermal formulations: hydrotropic solubilization of polyol fatty acid monoesters in water and enhancement effect on skin permeation of 5-FU.
    Takahashi K; Komai M; Kinoshita N; Nakamura E; Hou XL; Takatani-Nakase T; Kawase M
    J Pharm Pharmacol; 2011 Aug; 63(8):1008-14. PubMed ID: 21718283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimisation of cosolvent concentration for topical drug delivery - II: influence of propylene glycol on ibuprofen permeation.
    Watkinson RM; Guy RH; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2009; 22(4):225-30. PubMed ID: 19648784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A statistical experimental approach to cosolvent formulation of a water-insoluble drug.
    Stephens D; Li LC; Pec E; Robinson D
    Drug Dev Ind Pharm; 1999 Aug; 25(8):961-5. PubMed ID: 10434141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of cosolvent concentration and excipient composition in a topical corticosteroid solution.
    Varia SA; Faustino MM; Thakur AB; Clow CS; Serajuddin AT
    J Pharm Sci; 1991 Sep; 80(9):872-5. PubMed ID: 1800711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma compatibility of injectables: comparison of intravenous U-74006F, a 21-aminosteroid antioxidant, with Dilantin brand of parenteral phenytoin.
    Cox JW; Sage GP; Wynalda MA; Ulrich RG; Larson PG; Su CC
    J Pharm Sci; 1991 Apr; 80(4):371-5. PubMed ID: 1865339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Injectable phenytoin: problems of stability in solution].
    Francés A; García Martí A; Bruck M
    Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):9-12. PubMed ID: 9303825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.
    Kawakami K; Oda N; Miyoshi K; Funaki T; Ida Y
    Eur J Pharm Sci; 2006 May; 28(1-2):7-14. PubMed ID: 16406526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of compressed gas precipitation to enhance the dissolution behavior of a poorly water-soluble drug: generation of drug microparticles and drug-polymer solid dispersions.
    Muhrer G; Meier U; Fusaro F; Albano S; Mazzotti M
    Int J Pharm; 2006 Feb; 308(1-2):69-83. PubMed ID: 16324806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parenteral formulation and thermal degradation pathways of a potent rebeccamycin based indolocarbazole topoisomerase I inhibitor.
    Sato Y; Breslin D; Kitada H; Minagawa W; Nomoto T; Qin XZ; Karki SB
    Int J Pharm; 2010 May; 390(2):128-33. PubMed ID: 20074629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of fosphenytoin sodium.
    Fierro LS; Savulich DH; Benezra DA
    Am J Health Syst Pharm; 1996 Nov; 53(22):2707-12. PubMed ID: 8931812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of drug precipitation upon dilution of pH-controlled formulations.
    Narazaki R; Sanghvi R; Yalkowsky SH
    Mol Pharm; 2007; 4(4):550-5. PubMed ID: 17530775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of early characterization of physicochemical properties in developing high-dose intravenous infusion regimens for poorly water-soluble compounds.
    Jain A; Zheng W; Garad S; Weaver M; Panicucci R
    PDA J Pharm Sci Technol; 2010; 64(6):517-26. PubMed ID: 21502062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solubilities of trimethoprim and sulfamethoxazole at various pH values and crystallization of trimethoprim from infusion fluids.
    McDonald C; Faridah
    J Parenter Sci Technol; 1991; 45(3):147-51. PubMed ID: 1886043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solubility prediction of paracetamol in binary and ternary solvent mixtures using Jouyban-Acree model.
    Jouyban A; Chan HK; Chew NY; Khoubnasabjafari M; Acree WE
    Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):428-31. PubMed ID: 16595939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solubility and stability of phenytoin sodium when mixed with intravenous solutions.
    Carmichael RR; Mahoney CD; Jeffrey LP
    Am J Hosp Pharm; 1980 Jan; 37(1):95-8. PubMed ID: 7361779
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of oral liquid dosage forms of acetazolamide.
    Parasrampuria J; Das Gupta V
    J Pharm Sci; 1990 Sep; 79(9):835-6. PubMed ID: 2273470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulating a poorly water soluble drug into an oral solution suitable for paediatric patients; lorazepam as a model drug.
    van der Vossen AC; van der Velde I; Smeets OS; Postma DJ; Eckhardt M; Vermes A; Koch BC; Vulto AG; Hanff LM
    Eur J Pharm Sci; 2017 Mar; 100():205-210. PubMed ID: 28126558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of propylene glycol and glycerol infusions as treatments for ketosis in dairy cows.
    Piantoni P; Allen MS
    J Dairy Sci; 2015 Aug; 98(8):5429-39. PubMed ID: 26074245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.